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EXECUTIVE SUMMARY 
 
 
Lung cancer has the lowest survival rate of all cancers in adults, with only 13% of affected 
individuals in Australia surviving for five or more years following a diagnosis. It is generally 
recognised that early diagnosis of lung cancer could be an important factor in improving both 
the survival rate and patients’ quality of life. One way to facilitate the early diagnosis of lung 
cancer is to improve people’s awareness of the signs and symptoms of the disease (e.g. a 
persistent cough, coughing up blood, fatigue, and weight loss) and encourage them to attend 
their general practitioner (GP) for investigation of potential symptoms.   
 
The objective of this rapid review was to identify and examine lung cancer ‘signs and symptoms’ 
interventions which have been developed in Australia and OECD countries with similar 
healthcare settings (i.e. New Zealand (NZ), Canada, and the United Kingdom (UK)). This involved 
assessing the effectiveness of these interventions on influencing knowledge, attitudes, beliefs, 
and help seeking behaviours (e.g. GP visits) in the general community and at-risk groups (e.g. 
smokers, individuals from a low socio-economic background, culturally and linguistically diverse 
(CALD) communities.  In addition, the effectiveness of interventions designed to influence the 
knowledge, attitudes, beliefs, and behaviours of health professionals was also examined. 
 
A review of the academic and grey literature resulted in the identification of eight lung cancer 
‘signs and symptoms’ interventions: ‘I’ll tackle it soon’ (UK), ‘3 Week Cough’ (UK), ‘Be Clear on 
Cancer’ (UK), ‘Cough, cough, cough’ (NZ), ‘The Sooner the Better’ (NZ), ‘The Australian Lung 
Foundation’ (various programs; Australia), ‘Find Cancer Early’ (Australia), and ‘Detect Cancer 
Early’ (UK).  The primary aim of all of these interventions was to raise awareness of the signs and 
symptoms of lung cancer, and increase help seeking behaviour (e.g. seeking help from a GP or 
other healthcare professional). The interventions typically targeted a single sign and symptom 
(i.e. a persistent cough lasting for three weeks or more). However, the ‘Be Clear on Cancer’ 
intervention publicised additional lung cancer signs and symptoms such as coughing up blood, 
breathlessness, fatigue, chest/shoulder pain. 
 
The evidence for the effectiveness of these interventions was very limited.  For example, only two 
of the eight interventions had any evaluation data (‘I’ll tackle it soon’, and ‘3 Week Cough’).  
These data did indicate that the interventions had positive effects. For example, ‘I’ll tackle it 
soon’ led to a significant increases in GP visits for lung cancer, along with a 20% increase in chest 
x-rays and a 27% increase in lung cancer diagnoses. The ‘3 Week Cough’ intervention similarly led 
to a 23% increase in GP attendances for patients with a cough or other symptoms of lung 
cancer. Unfortunately, in addition to being limited in quantity, the quality of the evidence was 
assessed as being low.   
 
There was also no indication of whether these ‘signs and symptoms’ interventions led to changes 
in knowledge, attitudes, or beliefs. There were no data examining the effectiveness of these 
interventions on relevant at-risk populations such as individuals from lower socio-economic 
groups, indigenous groups, or CALD communities. Furthermore, although some of the 
interventions indicated that they included a component targeted towards health professionals, 
there are no published data examining the effects of these health professional components. As a 
consequence, it is not possible to determine whether lung cancer ‘signs and symptoms’ 
interventions are effective in influencing health professionals’ knowledge, attitudes, beliefs, and 
relevant behaviours. 
 
The very limited data for lung cancer ‘signs and symptoms’ interventions led to an expansion of 
the review to also encompass ‘signs and symptoms’ interventions for other relevant cancers such 
as breast cancer, prostate cancer, and colorectal cancer (a preliminary search was also 
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conducted for chronic obstructive pulmonary disease interventions, but recent published data 
were not available). This resulted in the identification of 11 relevant interventions for which 
evaluation data were available: five of these were for breast cancer, four for colorectal cancer, 
and two for prostate cancer. 
 
These interventions did focus on increasing awareness of cancer signs and symptoms, but had a 
range of other goals such as increasing visits to GPs and screening, and increasing detection 
rates of cancer. The evaluation data were considerably more detailed for these cancers relative 
to lung cancer. Several of the interventions led to significant improvements in knowledge and 
awareness of cancer signs and symptoms. For example, the ‘Be Clear on Cancer’ colorectal 
cancer campaign led to approximately 50% increase in awareness of symptoms (e.g. ‘blood in 
poo’). The ‘Learn, Share and Live’ intervention led to an increase in the percentage of women 
who indicated that they had recently been screened for breast cancer (from 40% to 68%).  
Furthermore, the ‘Screen for Life’ intervention was associated with a 19.3% increase in screening 
rates for colorectal cancer between 2002 and 2008.  There was also evidence of increases in visits 
to healthcare professionals.  For example, ‘Be Clear on Cancer’ led to a 48% increase in GP visits 
for colorectal cancer signs and symptoms.   
 
Unfortunately, the quality of the evaluation data was generally low. Therefore, although these 
interventions generally had positive effects on the outcome measures these need to be 
interpreted with caution. In particular, there is a need for more rigorous research designs (e.g. 
randomised control trials (RCTs), or well-designed observational studies that yield extremely large 
and consistent estimates of the magnitude of an intervention effect) to better determine the 
effectiveness of these interventions. Furthermore, as per the lung cancer ‘signs and symptoms’ 
interventions, evaluation data did not identify factors that influenced the effectiveness of these 
interventions, or whether effectiveness varied according to socio-economic or CALD status.   
 
The results of this rapid review indicate that very few ‘signs and symptoms’ interventions for lung 
cancer have been developed and trialled in Australia, NZ, the UK and Canada.  Based on the 
available data it is concluded that: 
Question 1a. ‘Signs and symptoms’ interventions may be effective influencing 
knowledge, attitudes, beliefs and help seeking behaviours such as visits to a GP or taking 
up screening. However the evidence base is limited, especially in relation to lung cancer, 
with some limited evidence from other cancer interventions suggesting a positive effect. 
 
Question 1b. There is very limited published evidence of the effectiveness of lung cancer 
‘signs and symptoms’ interventions targeted towards at risk population groups. 
 
Question 2. There is insufficient evidence to make any conclusions regarding 
interventions targeted towards health professionals 
 
Based on the available evidence, the following recommendations are made for developing lung 
cancer ‘signs and symptoms’ interventions in NSW. 
1. Interventions should be based on rigorous formative research with target population 
groups and stakeholders to generate understanding and useful insights regarding 
knowledge, attitudes, and behaviours, and explore issues, influences and barriers to 
increasing awareness and changing behaviour 
2. Segmentation of target populations – beyond simple demographic based approaches, 
but using formative research to identify psychographic audience segments can facilitate 
targeted and tailored intervention messages 
3. Capacity building and training with relevant stakeholders such as healthcare 
professionals can be helpful to alleviate concerns over resources and build support for 
intervention aims and objectives 
 EXECUTIVE SUMMARY 
 
The Sax Institute 7 
4. Future interventions should use relevant theories to help identify applicable factors 
influencing behaviour, and to develop behaviour change strategies 
5. Evaluation research models which include process, and cost effectiveness, as well as 
outcome evaluation data, should be built in at the start of future interventions as existing 
interventions do not report these data 
6. A social marketing framework can provide a comprehensive and strategic structure for 
incorporating the aforementioned recommendations. Social marketing has been shown 
to be an effective approach for colorectal cancer (Cancer Research UK 2007), and 
more widely for population health behaviour change interventions (Stead et al. 2007). In 
addition, utilising an internal social marketing approach – the application of internal 
marketing for the achievement of social rather than commercial objectives (Smith 2011), 
to engage relevant stakeholders in the healthcare sector can overcome barriers such as 
concerns over capacity and support in the system; and issues over procedures and 
protocols.
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1 Introduction 
 
 
Lung cancer is the fourth most commonly diagnosed invasive cancer in Australian adults 
(excluding basal cell carcinoma and squamous cell carcinoma), accounting for approximately 
8% of all cancers (Australian Institute of Health & Welfare (AIHW) 2010).  Lung cancer refers to any 
carcinoma that originates in the lungs (e.g. trachea, bronchi, bronchioles, & alveoli) and can be 
categorised according to two main types:  
1. Small cell carcinoma. This is the most aggressive form of lung cancer and spreads very 
rapidly during the early course of the disease. This means that by the time it is diagnosed, 
surgery (i.e. removal of the tumour) is often not an effective form of treatment, and the 
only options are radiotherapy or chemotherapy 
2. Non-small cell carcinoma. This is a less aggressive form of lung cancer that grows and 
spreads more slowly. Because the tumour tends to be confined to parts of the lung for a 
longer period of time, surgery is a more effective treatment option relative to small cell 
carcinoma.   
Lung cancer is a major public health issue as it has a higher mortality rate in both males and 
females than any other cancer (AIHW 2010). For example, only 13% of diagnosed individuals 
survive five years after diagnosis, which is considerably lower than the survival rates for breast 
cancer, prostate cancer, and bowel cancer (AIHW 2010). Lung cancer is more common in males 
than females; however, the magnitude of this difference has changed considerably over the 
past 30 years. In 1982, males were 4.7 times more likely to be diagnosed with lung cancer.  By 
2007, this had fallen to 1.8 times more likely (AIHW 2010). This reflected a 32% decline in the 
incidence of lung cancer in males between 1982 and 2007, and a concurrent 72% increase in 
incidence in females during the same period of time (AIHW 2010).     
 
The primary risk factor for lung cancer (particularly small cell carcinoma) is tobacco smoking, 
which accounts for 90% of all diagnoses in males and 65% of all diagnoses in females (AIHW 
2010). However, there are other notable risk factors for lung cancer which include: 
1. Second hand cigarette smoke 
2. Exposure to carcinogens (e.g. asbestos, diesel exhaust fumes)  
3. Radon exposure (naturally occurring radioactive gas released during normal decay of 
uranium in rocks and soil) 
4. Family history of lung cancer 
5. A history of lung disease. 
 
The relatively high incidence of lung cancer combined with the low survival rate means there is a 
need to identify and develop effective strategies to aid prevention. One major strategy has been 
anti-smoking policies and campaigns, given that smoking is the main risk factor for lung cancer 
(AIHW 2010; Baldwin & Hubbard 2012). Smoking cessation campaigns have been implemented in 
many countries, including Australia, and have been shown to be effective in reducing the age-
adjusted incidence of lung cancer (Baldwin & Hubbard 2012).   
 
However, a second strategy that requires considerable attention and development involves 
improving the early diagnosis of lung cancer. It is generally agreed that this could be achieved 
through a combination of screening interventions and, increasing public and health professional 
awareness of lung cancer signs and symptoms (AIHW 2010, Hamilton et al. 2005). Unfortunately, 
screening at a population level may not be an effective or efficient strategy at present given the 
lack of reliable screening methods (Hamilton et al. 2005). Interventions aimed at increasing 
INTRODUCTION 
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awareness of lung cancer signs and symptoms could be a more effective strategy for improving 
the survival rate of lung cancer and are the primary focus of this review.  The objective of this  
rapid review is to examine the evidence regarding the effectiveness of these ‘signs and 
symptoms’ interventions.  
 
   
Lung cancer ‘signs and symptoms’  
Lung cancer ‘signs and symptoms’ interventions have the potential to improve the early 
diagnosis of the disease. This is important because the low survival rate of lung cancer can be 
partially attributed to most patients being diagnosed at more advanced stages of the disease 
(AIHW 2010). This is compounded by the low awareness of lung cancer signs and symptoms both 
in the general community and amongst health professionals (Simon et al. 2012).  Strategies for 
increasing the recognition of signs and symptoms of lung cancer may be effective in improving 
the survival rate for this disease. 
 
The signs and symptoms of lung cancer vary depending on the stage and type of the disease.  
However, the most common signs and symptoms are (Hamilton et al. 2005): 
1. A persistent cough which has lasted for three or more weeks 
2. Haemoptysis - coughing up blood 
3. Weight loss 
4. Loss of appetite 
5. Dyspnoea - subjective reports of breathing difficulties, including breathlessness 
6. Fatigue 
7. Chest or rib pain 
8. Finger clubbing – this refers to a thickening of the skin on the fingertips, leading to an 
abnormal rounded appearance.  
 
Many of these symptoms (e.g. a persistent cough) are commonly presented by patients visiting a 
healthcare professional and quite often are indicative of another health condition (Hamilton et 
al. 2005). However, when there is a co-occurrence of two of more of these symptoms, the 
likelihood of lung cancer is increased dramatically (Hamilton et al. 2005). 
 
 
The present review 
A number of lung cancer ‘signs and symptoms’ interventions have recently been developed and 
implemented, particularly in the United Kingdom (UK). The purpose of this rapid review is to review 
available evidence regarding the effectiveness of these interventions.  This involves addressing 
two main questions: 
Question 1 
How effective are community-based ‘signs and symptoms’ interventions in influencing 
knowledge, attitudes, beliefs, and help seeking behaviours in: 
a. The general community? 
b. Population groups at increased risk of developing lung cancer (e.g. smokers, individuals 
with low socio-economic status, indigenous communities, rural and remote communities, 
culturally and linguistically diverse communities)? 
INTRODUCTION 
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Question 2 
a. How effective have lung cancer ‘signs and symptoms’ interventions for health 
professionals been in influencing knowledge, attitudes, beliefs, and health professional 
behaviours?   
b. What are the essential components of lung cancer ‘signs and symptoms’ interventions for 
health professionals that have been effective? 
 
In order to address these questions, we reviewed available academic and grey literature on lung 
cancer ‘signs and symptoms’ interventions from Australia and OECD countries with similar 
healthcare settings, particularly the UK, New Zealand and Canada.  This rapid review involves 
providing: 
1. An overview of available interventions and their characteristics 
2. A summary of the evidence of the effectiveness of these interventions 
3. An assessment of the quality of evidence for these interventions 
4. An indication of the factors influencing the success of these interventions (e.g. barriers 
and enablers) 
5. Recommendations that can be used to develop similar interventions in NSW. 
 
The effectiveness of these interventions is assessed in relation to the extent of: 
 Improvements in knowledge, attitudes and/or beliefs about lung cancer signs and 
symptoms.   Within this context, knowledge about cancer and its treatment is broadly 
defined to include knowledge about causes, risk factors, incidence, detection, survival 
rates, treatment options, and effectiveness of early detection  
 Increases in rates of early signs and symptoms recognition 
 Increases in rates of contact with healthcare professionals regarding signs and 
symptoms. 
 
It is noted that although several ‘signs and symptoms’ interventions have been implemented in 
these countries, evaluation data are very limited. Therefore, reference is also made to ‘signs and 
symptoms’ interventions developed for other cancers such as breast cancer, colorectal cancer, 
and prostate cancer. Evaluation of these interventions will be useful in informing the 
recommendations for future lung cancer interventions. 
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2 Methods 
 
 
Literature review 
In order to address Questions One and Two, we reviewed recent (i.e. 2002–2012) academic 
literature and grey literature to identify lung cancer ‘signs and symptoms’ interventions and 
associated evaluation data. The methodology utilised for the literature search is outlined below.   
1. Academic Literature.  A search of relevant academic literature published between 2002 
and 2012 was conducted in the search engines Web of Knowledge (encompasses Web 
of Science, Medline etc), Cochrane, Scopus, and Psycinfo using the following key words:  
 ‘lung cancer’ 
 AND 
 aware* OR prevent* OR cough OR breathlessness OR breath* 
 AND 
 campaign* OR program* OR intervention*. 
The reference lists of identified articles were scanned for any additional relevant 
publications that were not identified through the review. 
 
2. Grey Literature.  The following websites from Australia, New Zealand, the UK, and 
Canada were searched for relevant lung cancer ‘signs and symptoms’ interventions. 
 Australian Department of Health and Ageing 
 Australian state government health departments (e.g. NSW Ministry of Health, 
VicHealth, SA Health, WA Health,  Department of Health of the Northern Territory, 
Queensland Health 
 Cancer Institute NSW 
 Cancer Council NSW 
 National Health Service (NHS) UK 
 Cancer Research UK 
 Canada Health 
 Canadian Cancer Society 
 NZ Ministry of Health. 
 
A Google search was also conducted using the search terms for the academic literature search 
in an attempt to identify other lung cancer ‘signs and symptoms’ interventions, not reported in 
either body of literature. 
 
Identified interventions were reviewed to derive information on:  
- The characteristics of the intervention (e.g. description of the intervention, formative 
research, target groups, communication strategy, theoretical framework)  
- The evidence of the effectiveness of these interventions 
- An assessment of the quality of evidence for these interventions 
- Factors influencing the success of these interventions (e.g. barriers and enablers). 
METHODS 
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Methods for assessing the quality of evidence 
One of the aims of this rapid review was to assess the quality of evidence regarding the 
effectiveness of ‘signs and symptoms’ interventions.  In this review, the quality of data used to 
evaluate these interventions was determined using the Grading of Recommendations 
Assessment, Development, and Evaluation (GRADE) guidelines (Guyatt et al. 2011). This is a 
system for rating the quality of evidence for published articles that are included in systematic 
reviews.   
 
More detail on this rating system is provided in Appendix A. However, in brief, this is a rating 
system that assesses the quality of evidence from observational studies and RCTs against a 
number of criteria (e.g. study design, imprecision, bias).  Use of this rating system generates a 
quality of evidence score for a given study ranging from very low quality to very high quality.  The 
four quality levels are described briefly.   
 High quality – very confident that the estimated effects are close to the true effects 
 Moderate quality –  moderately confident that the estimated effects are close to the true 
effects 
 Low quality – there is only limited confidence in the estimated effect   
 Very low quality  – there is very little confidence in the estimated effect.  
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3 Results 
 
 
Overview of lung cancer ‘signs and symptoms’ interventions 
The review of the academic and grey literature identified eight interventions that made some 
reference to lung cancer signs and symptoms. One of these interventions was published in the 
academic literature – ‘I’ll tackle it soon’ (Athey et al. 2011). The remaining seven interventions 
were identified through grey literature: ‘3 Week Cough’ (UK), ‘Be Clear on Cancer’, ‘Cough, 
Cough, Cough’, ‘The Sooner the Better’, ‘The Australian Lung Foundation’ (various programs), 
‘Find Cancer Early’, and ‘Detect Cancer Early’.  
 
Furthermore, we identified three interventions that made some reference to lung cancer signs 
and symptoms: ‘Cough On’ (Canadian Lung Association), ‘3 week Cough’ (NZ), and the 
National Tobacco Campaign (Australia). These interventions were not included in the final list 
given that they did not directly link signs and symptoms with lung cancer and/or did not 
specifically have a relevant behavioural/attitudinal outcome (e.g. increase visits to a healthcare 
professional).  
 
Appendix B summarises the eight lung cancer ‘signs and symptoms’ interventions that were 
included in this review. The key characteristics of these interventions are described below.   
 
1. Goals of the intervention 
As shown in Appendix B, the primary goal of all eight interventions was to raise awareness of the 
signs and symptoms of lung cancer, and increase help seeking behaviour (often measured in 
terms of the number of visits to the GP or other relevant healthcare professional). All of the 
interventions targeted a persistent cough, typically lasting for 3 weeks or more. However, other 
signs and symptoms of lung cancer were not targeted by these interventions.  The only exception 
was ‘Be Clear on Cancer’ which also aimed to raise awareness of other lung cancer signs and 
symptoms such as coughing up blood, breathlessness, fatigue, and chest/shoulder pain.  
 
There may be some advantage in targeting only a limited number of lung cancer signs and 
symptoms.  For example, research suggests that communication interventions are more effective 
when the messages are simple. However, focusing on a single sign and symptom (persistent 
cough) is a potential limitation of these interventions given that recognition of other symptoms 
could also be very important. Therefore, future lung cancer ‘signs and symptoms’ interventions 
may benefit from focusing on more than one symptom.  These could include coughing up blood, 
breathlessness, fatigue, and chest/shoulder pain, which were also publicised in the ‘Be Clear on 
Cancer’ campaign.   
 
2. Formative research 
Only three of the eight interventions reported that they had conducted any formative research.  
It is possible that the remaining interventions did conduct formative research but did not report 
that they had done so.  Hence, this review is only able to discuss formative research in relation to 
the three interventions where this is reported. 
 
The ‘I’ll tackle it soon’ intervention run by the NHS was informed by focus groups with members of 
the community and consultations with relevant health professionals. The current ‘Be Clear on 
Cancer’ intervention also run by the NHS has been based on extensive formative research. This 
has included focus groups, as well as pilot testing in several smaller communities in the UK to test 
feasibility. New Zealand’s ‘The sooner the better’ intervention, run in the northern regions of the 
country, was also informed by extensive formative research. This included focus groups with 
members of the community and consultations with clinicians and researchers. 
RESULTS 
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The remaining five interventions did not report whether formative research was conducted.  This 
may be a key limitation because formative research is considered important in ensuring that the 
messages are being tailored appropriately to the target population. For example, it can provide 
insight into what moves and motivates target populations, and how they might be reached and 
influenced through awareness raising interventions. Pilot testing of messages and 
communications with the target population is also useful to test the suitability and effectiveness of 
intervention materials prior to launch. Therefore, it is recommended that any future intervention is 
formulated on the basis of extensive formative research and pilot testing.    
 
3. Target Groups 
The eight interventions differed in regards to the groups that were targeted. One intervention 
(‘Cough, cough, cough’) had no clear target group.  Five interventions were targeted towards 
middle aged adults (‘3 Week Cough’ and ‘I’ll tackle it soon’ were targeted at adults aged 50 
years and over, ‘Be Clear on Cancer ‘ targeted at adults aged 55 years and over, ‘The sooner 
the better’ Maori and Pacific Islanders aged 45-64 years, and ‘Find Cancer Early’ targeted adults 
aged 40 years and over. In addition, the ‘Be Clear on Cancer’ and ‘I’ll tackle it soon’ 
interventions were also targeted towards individuals with lower socio-economic status. ‘The 
sooner the better’ intervention is the only intervention we identified that is targeted towards a 
specific ethnic group (Maori and Pacific Islanders). The ‘I’ll Tackle it Soon’ and ‘Cough, cough, 
cough’ interventions reported that they also specifically targeted smokers. However, it should be 
acknowledged that the majority of interventions targeted at risk populations in locations in which 
smoking prevalence is high. The ‘I’ll Tackle it Soon’ intervention specifically did not mention 
cancer or make reference to smoking to overcome barriers relating to fatalism about lung 
cancer and stigma attached to smoking (Athey et al. 2011). 
 
Segmentation and targeting of particular population groups is an important component of 
effective awareness raising and health behaviour change interventions (Stead et al. 2007).  This is 
because various groups may have different attitudes, beliefs and behaviours, and hence may 
respond different to messages and cues to action. Therefore, future lung cancer ‘signs and 
symptoms’ interventions should include segmentation and targeting of different population 
groups informed by the insights from formative research with the relevant audience. Importantly, 
a more sophisticated segmentation approach with consideration for segmenting target groups 
according to psychographic variables (e.g. attitudes, beliefs) as well as demographic variables 
(particularly socio-economic status and CALD) should be adopted in lung cancer ‘signs and 
symptoms’ interventions. Interestingly, the current review found no direct evidence of 
psychographic segmentation in the available literature; it is possible that this was examined in 
some interventions but has not been published.   
 
4. Theory 
None of the interventions were reported to have been informed by relevant theory. Consistent 
with the discussion surrounding formative research and psychographic segmentation, it is possible 
that at least some of the interventions did use theoretical frameworks but did not report this 
information. This is a common occurrence in many health interventions, whereby relevant 
theories are used but are not reported in academic or grey literature.    
 
Use of relevant theories such as the Theory of Planned Behaviour and the Health Belief Model is 
important as it provides a useful framework for understanding health behaviours such as seeking 
help from a health professional (Glanz et al. 2008). As noted in more detail below, ‘signs and 
symptoms’ interventions that have been developed for other cancers have used frameworks 
such as social cognitive theory (Bandura, 1988) to inform messages and materials. We 
recommend that future lung cancer ‘signs and symptoms’ interventions also incorporate relevant 
behaviour theories. 
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5.  Communication Strategy 
Most of the interventions delivered messages through a variety of media including: 
 Face-to-face events such as road-shows in public venues such as shopping centres 
featuring media personalities, information and campaign materials (e.g. ‘Be Clear on 
Cancer’) linked in with existing events such as fetes, sports activity and open days 
 Radio and television advertising 
 Posters and Billboards 
 Online through campaign and relevant stakeholder’s websites, and social media such as 
e-bulletins, e-newsletters, Twitter feeds, Facebook pages, and articles disseminated on 
social media sites (e.g. ‘Be Clear on Cancer’ and ‘3 Week Cough’) 
 Leaflets. 
The most comprehensive communication strategy has been adopted by the ‘Be Clear on 
Cancer’ intervention which, as a national campaign, uses multiple communication channels on 
a large scale. Other interventions implemented on a smaller scale utilised less expensive media 
such as newspaper articles, leaflets, and online information. Unfortunately, this level of detailed 
information is not included in the publications identified in the review. Exploratory research and 
pre-testing should be able to propose/identify suitable channels of communication with the 
target audience(s). 
 
6.  Outcomes 
One of the major limitations of the existing literature is that there is a lack of evaluation data 
examining effectiveness of lung cancer ‘signs and symptoms’ interventions.  Only two of the lung 
cancer ‘signs and symptoms’ interventions have corresponding evaluation data – ‘I’ll tackle it 
soon’ and ‘3 Week Cough’ – of which only the results of ‘I’ll tackle it soon’, have been published 
in peer reviewed literature (Athey et al. 2011). Both interventions were linked, as they were 
administered under the NHS framework, and learning from these interventions was used to 
develop the national ‘Be Clear on Cancer’ intervention. 
 
‘I’ll tackle it soon’ was a community based social marketing intervention to raise awareness of 
lung cancer signs and symptoms, and increase presentations for healthcare (Athey et al. 2011). 
Social marketing is defined as the “the systematic application of marketing, alongside other 
concepts and techniques, to achieve specific behavioural goals for a social good” (French and 
Blair-Stevens 2007). The intervention was conducted among six at-risk communities with high 
levels of smoking prevalence, and low socio-economic status in Doncaster, England during 2008.  
The main target group was males aged over 50 who had ever smoked and worked in heavy 
industry, and their family members. It featured core social marketing intervention criteria 
including customer orientation and insight generated through formative research, segmentation 
and targeting, addressing the competition (e.g. barriers to the desired behaviour), and use of the 
marketing communications mix. Formative research identified a number of issues and barriers to 
awareness of, and presentation to a health worker in relation to, lung cancer signs and 
symptoms. These included a lack of clarity and understanding of symptom experience, a lack of 
knowledge of lung cancer signs and symptoms, and fear including a lack of knowledge of 
treatments and fatalistic beliefs. Blame and stigma attached to smoking were also powerful 
influences. Cultural factors such as stoicism, and an unwillingness to complain, waste time or use 
healthcare resources unnecessarily, were also identified. The formative research also revealed 
that the role families played could be crucial in overcoming delays in recognising signs and 
symptoms and presenting for assessment and treatment. 
 
Exploratory research for ‘I’ll Tackle it Soon’ also identified that there were concerns among 
primary caregivers over becoming overloaded with referrals, the risks associated with x-rays, and
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 confusion over when to re-refer if an x-ray was normal but symptoms persisted. Furthermore, in 
the secondary care setting there was concern over capacity in radiology and along the lung 
cancer pathway (Tod et al. 2008). 
 
The intervention was designed and delivered to account for the insights generated from the 
formative research. The project aimed to increase the number of symptomatic patients 
presenting at GP surgeries and to increase x-ray referrals by 20%. Two complementary 
interventions were developed, with a push-pull approach being utilised. The present element 
included a public awareness media campaign, media and public relations activities such as 
face-to-face events and conversations focusing on raising awareness of the importance of 
seeking help and advice for a cough lasting more than three weeks. 
 
A three week cough was selected as the focus due to evidence suggesting it may be associated 
with a better prognosis and to ensure simplicity of the message. In addition, focusing on this 
symptom is useful because if the cough is not a sign of cancer (or another serious disease) then it 
would normally resolve with antibiotics within three weeks. Intervention messages informed by the 
formative research did not specifically mention cancer, or smoking, addressing barriers to help 
seeking behaviour. The pull element of the intervention included brief intervention training to 
prepare healthcare workers for the intervention and reassure them of capacity in the system. 
Extensive training was conducted with community pharmacists, GP practices and other 
healthcare workers involved in the lung cancer pathway. 
 
The evaluation data indicated that 21% of the target population (128/600) recalled the 
intervention. Compared with a respondent in the control area, a participant in the intervention 
area was 1.97 times more likely to indicate they would visit their general practitioner and request 
a chest x-ray for a cough. Primary care chest x-ray referral rates increased by 20% in the targeted 
practices in the year following the intervention compared with a 2% fall in the control practices; 
this difference was statistically significant. There was a 27% increase in lung cancer diagnoses in 
the intervention area compared with a fall in the control area. Evaluation of the intervention did 
not report data regarding the effectiveness of the intervention on attitudes, beliefs, or knowledge 
regarding lung cancer signs and symptoms. 
 
The second intervention for which we identified evaluation data was the ‘3 Week Cough’ 
intervention, which was a five week pilot study to increase awareness of lung cancer signs and 
symptoms conducted in the Midlands of England in 2011. The intervention was targeted at adults 
aged 50 years and over. The intervention aimed to increase visits to a GP among the target 
population when aware of suspected signs and symptoms of lung cancer. Although formative 
research was not reported in the literature, the intervention was linked to the previous ‘I’ll tackle it 
soon’ study in Doncaster, and could therefore be assumed to use learning and insights from it. 
The intervention featured a mass media campaign using television and radio advertising, posters 
in GP surgeries, and face-to-face events in the community. This involved brief intervention training 
of health professionals, community pharmacists, community development workers, and cancer 
information workers; as well as community influencers such as community leaders, community 
champions and volunteers, who were tasked with having conversations about a 3 week cough 
with the target audience and advise people how to act. 
 
It was not reported whether the intervention utilised behavioural theory. Evaluation of the 
intervention found that it was responsible for a 23% increase in GP attendances for patients with a 
cough or suspected of having lung cancer.   
 
Data identifying factors influencing the effectiveness of these interventions were not reported.  
Furthermore, it is not clear whether these interventions were more or less effective in CALD 
communities or among individuals from different socio-economic backgrounds. 
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‘Signs and symptoms’ interventions – breast, colorectal, and 
prostate cancer 
Given the lack of evidence regarding lung cancer ‘signs and symptoms’ interventions and 
accompanying evaluation data, we supplemented the review by conducting additional 
literature searches to identify published ‘signs and symptoms’ interventions for: 
 Breast cancer 
 Colorectal cancer  
 Prostate cancer. 
 
 
Search strategy 
A search was conducted for relevant academic review articles published between 2002 and 
2012 in the search engines Web of Knowledge (encompasses Web of Science, Medline etc), 
Cochrane, Scopus, and Psycinfo using key words such as:  
 ‘breast cancer’ OR ‘bowel cancer’ OR ‘colorectal cancer’ OR ‘colon cancer’ OR 
‘prostate cancer’ 
 AND 
 aware* OR prevent* OR signs OR symptoms 
 AND 
 campaign* OR program* OR intervention*. 
 
From these searches we identified one relevant systematic review of interventions to promote 
cancer awareness and early presentation (Austoker et al. 2009), which included evaluation of 
four breast cancer interventions (Rimer et al. 2002; Skinner et al. 2000; Catalano et al. 2003 and 
Gabram et al. 2008). We also identified one further breast cancer intervention with a signs and 
symptoms component (Linsell et al. 2009). Therefore, a total of five breast cancer interventions 
were included in the review. 
 
We identified four colorectal cancer interventions featuring a signs and symptoms component for 
inclusion in the review: ‘Be Clear on Cancer’, ‘Screen for Life’ (Jorgensen et al. 2001), ‘West of 
Scotland Cancer Awareness Project’ (WoSCAP) (Eadie and MacAskill 2002, 2008) and a 
colorectal cancer intervention developed by Broadwater et al. (2004).  
 
In addition, we identified two interventions for prostate cancer which featured a signs and 
symptoms component: Lyzun and McMullen (2008), and Ilic et al. (2007).  
 
In summary, from these additional searches we identified 11 interventions, five breast cancer, four 
colorectal cancer, and two prostate cancer interventions containing a signs and symptoms 
component, the results of which are presented in Appendix C.  
 
Rather than reviewing all of these interventions in detail, we present a rapid review of key 
features pertaining to breast, colorectal and prostate cancer interventions with a signs and 
symptoms component for which published evaluation data are available.  
 
1. Behaviour change goal 
The behaviour change goals varied between the interventions, which is not surprising given that 
the aims and scope of these interventions were also quite different. Six of the 11 interventions 
were targeted towards increasing health seeking behaviours. In particular, four interventions 
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aimed to increase the number of visits to a healthcare professional (e.g. a GP) for symptoms 
associated with the relevant cancer. Two of the interventions aimed to increase screening 
behaviours (e.g. mammography). Another common goal of these interventions was to increase 
awareness of cancer (including signs and symptoms); this was reported in five of the 11 
interventions. The other interventions had goals such as increasing the rates of detection (3/11 
interventions). 
 
2. Formative research 
Nine of the 11 interventions indicated that they had performed some formative research; this 
varied from a simple literature review to in-depth consultations with relevant stakeholders and 
testing of intervention materials. 
 
Formative research indicated that awareness of cancer signs and symptoms is low, particularly in 
low socio-economic or CALD communities (e.g. Eadie and MacAskill 2002). Furthermore, 
concerns about embarrassment, putting unnecessary strain on the healthcare system, and 
fatalistic beliefs about cancer can act as barriers to action by target populations. Interventions 
that conducted extensive formative research with the target audience enabled segmentation 
and targeting strategies to be deployed (e.g. Rimer et al. 2002). This provided tailored print 
materials and telephone counselling to participants based on data from a baseline telephone 
interview. Therefore, formative research can often be vital in generating insight on the target 
audience’s knowledge, attitudes and behaviours, identifying barriers to behaviour change, and 
exploring themes that can inform intervention messages and materials. Interventions that are 
able to take a more sophisticated segmentation and targeting approach, beyond simple 
demographic breakdowns and involving psychographic segmentation, have also been shown to 
be effective (Jones et al 2010). 
 
3. Target Groups 
The specific groups targeted in these interventions varied quite considerably.  This is not surprising 
given the different target cancers (e.g. prostate versus breast cancer) and the intervention 
settings. Despite these variations, a key finding is that the majority of these interventions clearly 
identified a target group.  For example, several of the interventions identified groups on the basis 
of age, particularly middle aged and older adults; socio-economic status, predominantly low 
socio-economic groups (Mayden Research 2012); ethnicity such as African-American women 
(Gabram et al. 2008); and/or geography, a specific city or region such as the West of Scotland 
(Eadie and MacAskill 2002).  
 
4. Theory 
Five of the 11 ‘other cancer’ interventions identified made use of behavioural theories. The 
relevant theories are briefly outlined below. 
 
One intervention (Rimer et al. 2002) used the Transtheoretical Model (Prochaska and DiClemente 
2005).  This model proposes the following five stages of change that need to be negotiated when 
trying to encourage a new health behaviour:  
1. Pre-contemplation: People are not intending to take action for the foreseeable future  
2. Contemplation: People are intending to take action in the next six months  
3. Preparation: People are intending to take action in the immediate future  
4. Action: People have made changes to their lifestyles in the past six months  
5. Maintenance: People are trying to prevent relapse to previous behaviour(s). 
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The theory also proposes a termination stage, whereby a person has fully adopted the new 
behaviour and will not return to the old behaviour. However, this is a theoretical concept, since 
very few people will ever reach this stage.   
 
The WoSCAP utilised Social Cognitive Theory (Bandura 1988), to inform their intervention. This 
model proposes that individuals learn behaviour through their interactions with other people in 
their social network and by observing other people (e.g. people on television). Observing these 
‘models’ can influence an individual’s attitudes regarding a behaviour, which can translate into 
changes in behaviour. Social Cognitive Theory also incorporates psychological constructs such as 
self-efficacy and outcome expectancies, which also influence the adoption of behaviours.  
 
Skinner et al. (2000) used a combination of Social Cognitive Theory and the Health Belief Model 
(see Rosenstock 1966); the latter is a psychological model used to predict health behaviours. The 
model is based on four constructs of the core beliefs of individuals, based upon their perceptions.   
1. Perceived susceptibility (a person’s view on their risk of getting the condition) 
2. Perceived severity (a person’s view of the seriousness of the condition and the 
consequences)  
3. Perceived barriers (a person’s view of the factors that facilitate or discourage adopting 
the promoted behaviour)  
4. Perceived benefits (a person’s view of the positive consequences of adopting the 
behaviour). 
 
The Screen for Life intervention used a combination of Social Cognitive Theory and the Theory of 
Planned Behaviour (Ajzen 1991). The Theory of Planned Behaviour is a widely used theory to 
understand and predict behaviour across of variety of domains. The model proposes that an 
individual’s behaviour is the result of: 
1. The individual’s attitude towards the behaviour 
2. The individual’s perceptions of how other people (e.g. friends, family, work colleagues 
etc) feel about the behaviour (subjective norms) 
3. How confident the individual feels about engaging in the behaviour (perceived 
behavioural control) 
4. Intentions to engage in the behaviour. 
 
One intervention (Linsell et al. 2009) used a theoretical model developed by Bish et al. (2005).  This 
theoretical model aimed to understand some of the factors that influence help seeking 
behaviours in the context of breast cancer symptoms. The authors developed a model whereby 
they attempted to explain how attitudes, intentions, and knowledge of symptoms interacted to 
influence help seeking behaviours. 
 
5.  Communication strategy 
The communication strategies adopted by the interventions also varied considerably depending 
on the scope of the intervention, the target groups, and the target cancer. For example, the 
Australian intervention tested by Ilic et al. (2007) involved distributing educational materials to 
male patients attending a medical centre. In contrast, other interventions such as ‘Be Clear on 
Cancer’, the WoSCAP, and ‘Screen for Life’ utilised a variety of communication channels that 
aimed to reach a variety of audiences including the target group, friends and family, 
pharmacies, and a variety of healthcare workers involved in the cancer treatment pathway 
including GPs, consultants, nurse specialists and radiographers. For example, in support of the ‘Be 
Clear on Cancer’ intervention, Bowel Cancer UK and the Royal College of General Practitioners 
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(RCGP) developed a new bowel cancer resource pack which was sent to GPs across the two 
regions in which the intervention was piloted. 
 
Communication strategies identified in the interventions identified included: 
 Television and radio advertising 
 Posters  
 Public relations events 
 Brochures and fact sheets 
 Training of healthcare workers 
 Stakeholder engagement 
 Peer educators 
 Websites 
 Physical products – e.g. testing kits. 
 
6.  Outcomes 
In general, most of the interventions had positive outcomes. Several of the interventions led to 
significant improvements in knowledge and awareness of cancer signs and symptoms. For 
example, the ‘Be Clear on Cancer’ intervention which was aimed towards colorectal cancer led 
to an approximate 50% increase in awareness of symptoms (e.g. ‘blood in poo’).    
 
Several of the interventions also led to significant increases in cancer screening behaviour.  
‘Learn, Share and Live’ led to an increase in the percentage of women who indicated that they 
had recently been screened for breast cancer (from 40% to 68%). ‘Screen for Life’ was 
associated with a 19.3% increase in screening rates for colorectal cancer between 2002 and 
2008; there was also evidence for increases in visits to healthcare professionals. ‘Be Clear on 
Cancer’ led to a 48% increase in GP visits for colorectal cancer signs and symptoms.   
 
Unfortunately, the quality of the evaluation data was generally low. Four of the interventions had 
a high level of quality, whereas six had low quality and one had very low quality. Therefore, 
although these interventions generally had positive effects on the outcome measures these need 
to be interpreted with caution.  In particular, there is a need for more rigorous research designs 
(e.g. RCTs or well-developed observational studies) to better determine the effectiveness of these 
interventions. Furthermore, as per the lung cancer ‘signs and symptoms’ interventions, evaluation 
data did not identify factors that influenced the effectiveness of these interventions, or whether 
effectiveness varied according to socio-economic or CALD status. 
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4 Discussion  
 
 
This rapid review was conducted to identify lung cancer ‘signs and symptoms’ interventions from 
Australia, New Zealand, Canada, and the UK.  There were two main findings from this review.  
First, there are few very ‘signs and symptoms’ interventions for lung cancer that have been 
developed and trialled in these countries. All eight interventions identified were targeted 
specifically towards members of the general community (Question 1) and only contained 
components targeted towards health professionals – ‘I’ll tackle it soon’ – (Question 2), which 
aimed to increase awareness of, and preparedness for, the intervention amongst health 
professionals. Training also reassured healthcare workers that there was sufficient capacity in the 
system to deal with increases in presentation and treatment. Second, evaluation data for these 
interventions are very scarce. For example, of the eight relevant interventions identified, only two 
had evaluation data. Furthermore, the data were published for only one of these interventions 
(‘It’ll go soon’) and the quality of the evidence was low.    
 
The lack of data for lung cancer ‘signs and symptoms’ interventions led to an expansion of the 
literature search to also include other cancers such as breast, colorectal, bowel, and prostate 
cancer. Although evaluation data were available for several of these interventions, the evidence 
base remains limited. Therefore, although this rapid review does attempt to provide 
recommendations for the development of future lung cancer ‘signs and symptoms’ interventions 
within the NSW context, it is emphasised that these are based on very limited data. Therefore, the 
recommendations and conclusions should be treated with caution, and we would strongly 
encourage any future interventions to utilise formative research with the target audiences to 
inform their design and implementation.  
 
We are able to draw the following conclusions based on available data:   
 
Question 1  
How effective are community-based ‘signs and symptoms’ interventions in influencing 
knowledge, attitudes, beliefs, and help seeking behaviours in: 
a. The general community? 
b. Population groups at increased risk of developing lung cancer (e.g. individuals with low 
socio-economic status, indigenous communities, rural and remote communities, CALD)? 
 
‘Signs and symptoms’ interventions may be effective influencing knowledge, attitudes, beliefs 
and help seeking behaviours (e.g. seeking help from a GP, screening behaviours). However the 
evidence base is limited, especially in relation to lung cancer, with some limited evidence from 
other cancer interventions suggesting a positive effect. Further published intervention studies are 
required to build the evidence base in this regard. 
 
There is very limited evidence (whether published in academic journals or reported in grey 
literature) regarding the effectiveness of lung cancer ‘signs and symptoms’ interventions 
targeted towards at risk population groups. There is reasonable evidence to suggest that ‘signs 
and symptoms’ interventions for other cancers can increase levels of knowledge, attitudes, 
beliefs, and help seeking behaviour among low socio-economic groups. There is limited evidence 
that such interventions can increase levels of health seeking behaviour among CALD 
communities (e.g. African America women), however there is a paucity of published research. 
Unfortunately, there are insufficient data to identify factors affecting the effectiveness of 
interventions targeting rural and remote communities, and the majority of interventions included 
in the review were in urban or suburban environments.   
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Further exploratory research is required to investigate knowledge, attitudes, behaviours, and 
barriers in relation to awareness of lung cancer signs and symptoms and cues to action. Some of 
these barriers may include: lack of clarity and understanding of symptoms experience, lack of 
knowledge of lung cancer signs and symptoms, fear including a lack of knowledge of treatments 
and fatalistic beliefs. Stigma and cultural influences including stoicism, an unwillingness to 
complain, waste time or use healthcare resources unnecessarily may also be additional barriers.  
 
Families and significant others could also be crucial in overcoming delays in recognising signs 
and symptoms and presenting for assessment and treatment (Athey et al. 2011). 
 
Several cancer interventions included in the review utilised a social marketing approach to 
behaviour change including ‘I’ll tackle it soon’, WoSCAP, ‘Detect Cancer Early’ and ‘Prostate 
Man’. Furthermore, other interventions such as ‘Be Clear on Cancer’ used social marketing 
principles such as using formative research to gain insight, and taking a consumer (patient) 
oriented approach to behaviour change, but were not explicitly described as social marketing.  
It is likely that ‘Be Clear on Cancer’ is not overtly described as social marketing due to the 
change in UK Government in 2010 and the interest in ‘Nudge Theory’ (or ‘Behavioural 
Economics’) which is favoured by the government. This has led to less visible support for social 
marketing from policy makers. 
 
Question 2.   
a. How effective have lung cancer ‘signs and symptoms’ interventions/campaigns for 
health professionals been in influencing knowledge, attitudes, beliefs, and health 
professional behaviours?   
b. What are the essential components of lung cancer ‘signs and symptoms’ 
interventions/campaigns for health professionals that have been effective? 
 
There is insufficient evidence to make any conclusions regarding interventions targeted towards 
health professionals. Increasing awareness among healthcare workers and addressing concerns 
over capacity and protocol for x-rays and treatment were components of the ‘I’ll tackle it soon’ 
intervention. However, outcome evaluation from this intervention did not measure any impact on 
knowledge, attitudes, beliefs and health professional behaviours.  
 
Interventions for other cancers such as WoSCAP successfully engaged a range of stakeholders in 
the process of delivering the intervention which appear to contribute to its success. Process 
evaluation of WoSCAP (Cancer Research UK 2007) outlines how an internal social marketing 
approach (see Smith and O’Sullivan 2012) was effective at co-opting over 45,000 healthcare 
workers including clinicians, GPs, pharmacists, NHS management, public health consultants and 
health promotion staff across the region.  
 
With respect to question 2b, formative research that informed the development of the ‘I’ll tackle 
it soon’ intervention (see Suckling 2010) identified that there were concerns among healthcare 
workers on the implications of running a lung cancer signs and symptoms awareness intervention. 
There were concerns over becoming overloaded with referrals, over the risks associated with x-
rays and radiation exposure, and there was confusion over when to re-refer a patient if an x-ray 
was normal but their symptoms persisted. In addition, there were concerns over capacity in 
radiology, and more generally along the lung cancer pathway (Tod et al. 2008). The ‘I’ll tackle it 
soon’ intervention addressed these issues through awareness raising and training with healthcare 
workers. Therefore, from this limited evidence, it could be suggested that future interventions 
should investigate whether similar concerns, and ways of addressing them, are present. 
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5 Gaps in the literature 
 
 
As discussed earlier, further research is required to generate greater understanding and insight on 
the issues, influences on, and barriers in relation to awareness of lung cancer signs and symptoms 
and presentation for advice and help. Currently, there is little published formative research with 
at risk populations regarding lung cancer, and their awareness of signs and symptoms of the 
disease. Indeed, the entire area of lung cancer ‘signs and symptoms’ awareness raising 
interventions is relatively new, with further evidence likely to become available in the coming 
months and years. Additional studies which conduct exploratory research will contribute 
considerably to the evidence base.   
 
In addition, there is little in the extant literature regarding the segmentation of target populations 
according to psychographic variables. Existing interventions do not appear to have made 
judicious use of behavioural theory to inform development and implementation. Furthermore, 
there is evidence from other cancer interventions that using theory is useful for informing 
intervention messages and materials.   
 
The majority of data currently available is from the UK, therefore interventions in other countries 
would be useful to build the evidence base, and assess the effectiveness of lung cancer ‘signs 
and symptoms’ interventions in other domains. There is also little evaluation data currently 
available in this area, and little to none on process evaluation and cost effectiveness. Therefore, 
future interventions that include a comprehensive evaluation framework providing data on 
process, outcomes and cost effectiveness would be helpful. 
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6 Recommendations 
 
 
The following recommendations are made based on the findings of the review, to inform the 
development of lung cancer ‘signs and symptoms’ interventions in NSW. 
1. Interventions should be based on rigorous formative research with target population 
groups and stakeholders to generate understanding and useful insights regarding 
knowledge, attitudes, and behaviours, and to explore issues, influences and barriers to 
increasing awareness and changing behaviour 
2. Segmentation of target populations – beyond simple demographic based approaches 
but using formative research to identify psychographic audience segments will enable 
targeted and tailored intervention messages and communication channels and 
materials to be used 
3. Capacity building and training with relevant stakeholders such as community members 
and healthcare professionals can be helpful to alleviate concerns over resources and 
build support for intervention aims and objectives 
4. Future interventions would benefit from the use of relevant theories to help identify 
relevant factors influencing behaviour, and to develop strategies to change behaviours 
5. There is a need to develop and test interventions targeting specific at-risk groups 
6. Evaluation research models which include process, and cost effectiveness, as well as 
outcome evaluation data, should be built in at the start of future interventions, as existing 
interventions do not report these data 
7. Social marketing offers a comprehensive and strategic framework for incorporating the 
aforementioned recommendations, and has been demonstrated to be an effective 
approach for colorectal cancer (Cancer Research UK 2007), and more widely for 
population health behaviour change interventions (Stead et al. 2007). In addition, utilising 
an internal social marketing approach—the application of internal marketing for the 
achievement of social rather than commercial objectives (Smith 2011), to engage 
relevant stakeholders in the healthcare sector can overcome barriers such as concerns 
over capacity and support in the system; and issues over procedures and protocols 
8. There is also a need to work with a range of agencies to expand the knowledge base 
surrounding lung cancer signs and symptoms. 
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Appendix A. Quality grading 
 
 
The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) 
guidelines (Guyatt et al. 2011). This is a system for rating the quality of evidence in systematic 
reviews and takes into account: 
1. Study design – randomised controlled trials receive a higher initial quality score 
compared with observational studies   
2. Risk of Bias – there can be a risk of misleading results if the study design or conduct is 
flawed (e.g. poorly developed eligibility criteria, failure to control for confounding) 
3. Imprecision – optimal approach to imprecision is the examination of the 95% confidence 
interval (CI).  CI informs the impact of random error on the evidence quality 
4. Inconsistency – a body of evidence is not rated up in quality if studies yield consistent 
results but may be rated down in quality if inconsistent 
5. Indirectness – evidence can be indirect in 4 ways. Patients may differ from those of 
interest, tested intervention may differ from intervention of interest, outcomes (or 
‘surrogate outcomes’) differ from those of primary interest and when clinicians must 
choose between interventions. When there is no head to head comparison of the study, 
the quality of evidence decreases as the use of indirect comparison is needed. Rating 
down occurs when there is a large discrepancy between these 4 points of indirectness 
6. Publication bias – even if individual studies are perfectly designed and executed, 
synthesis of studies may provide biased estimates. This is partly since there may be a bias 
in journals publishing negative or no results (eg. overestimating effect size)  
7. Rating up the quality of evidence – most common reason is evidence of a large effect. 
Rate up 1 level if study shows at least a 2-fold reduction or increase in risk, and rate up 2 
levels for at least a 5-fold reduction or increase in risk. Consider rating up if a systematic 
review shows evidence of a dose response gradient. Need to consider other criteria for 
rating down quality of evidence before employing this concept though. 
28 The Sax Institute 
 
Appendix B. Lung cancer interventions with a ‘signs and symptoms’ component 
Campaign 
Country and 
Year 
Description of Campaign Campaign Characteristics Results 
I’ll tackle it soon 
(NHS) 
Athey et al. 2011. 
Tod et al. 2008. 
UK, 2008  This was a pilot awareness raising campaign 
implemented in Doncaster (UK) in early 2008.  The 
campaign involved two complementary components.    
The push element involved a public awareness 
campaign that focused on raising awareness of the 
importance of seeking medical advice and requesting 
a chest x-ray for a cough lasting more than 3 weeks.  
The pull aspect involved brief interventions to 
prepare healthcare professionals for the intervention 
and to assure them that there was sufficient capacity 
to deal with the increased referrals.   
 
1. Behaviour Change Goal: increase visits to GP and x-ray referrals 
2. Formative Research: Focus groups, consultations with health professionals 
3. Target Groups: six at risk communities with high smoking rates and low socio-
economic status in Doncaster, England. Specifically targeted at men over 50 
years who had ever been smokers and worked in heavy industry and their 
family members 
4. Theory: not reported but did use the five elements model of strategic 
community engagement: grassroots community work, community 
infrastructure, professional infrastructure, organisation development, and 
overview and coordination 
5. Communication Strategy: utilised a range of media such as newspapers, 
leaflets, radio, and billboards, face-to-face events, and conversations. 
20% increase in chest  
x-rays. 
Significant increase in GP 
visits. 
27% increase in lung 
cancer diagnoses. 
Quality of evidence: Low 
(controlled trial – no 
randomisation). 
3 Week Cough (NHS) 
Suckling 2010. 
Elliott & Stacey 2010. 
UK, 2011 Five week pilot campaign trialled in the Midlands 
(UK) in 2011.  The campaign aimed to increase 
awareness of lung cancer signs and symptoms.    
1. Behaviour Change Goal: increase help seeking behaviour (e.g. increased 
presentations to a GP) 
2. Formative Research: not reported 
3. Target Groups: Adults aged 50 years and over 
4. Theory: not reported 
5. Communication Strategy: utilised a range of media including television, radio, 
out of home advertising (e.g. TV screens in GP surgeries) and face-to-face 
event. 
23% increase in GP 
attendances for patients 
with a cough or suspected 
of having lung cancer. 
 
Quality of evidence: low. 
Lung cancer interventions with a ‘signs and symptoms’ component 
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Campaign 
Country and 
Year 
Description of Campaign Campaign Characteristics Results 
Be Clear on Cancer 
(NHS) 
Freud 
Communications 
2012 
 
 
UK, 2012 This two month campaign is part of a larger national 
cancer awareness campaign, addressing breast, lung, 
bowel, and prostate cancer.  The key messages of 
the lung cancer campaign focus on the importance of 
early detection of lung cancer. It also aims to 
increase awareness of lung cancer signs and 
symptoms (e.g. coughing up blood, persistent cough, 
breathlessness, fatigue, chest/shoulder pain).   
1. Behaviour Change Goal: increase visits to GP 
2. Formative Research: Informed by pilot studies (e.g. 3 week cough) 
3. Target Groups: Adults aged 55 years and over, with a focus on individuals from 
lower socio-economic groups 
4. Theory: not reported 
5. Communication Strategy: television, radio, print, online, and social media, with 
face-to-face events, and national and regional PR activity.  Material also 
developed for GPs to prepare them for the increase in referrals and to gain 
their support in increasing screening for lung cancer. 
Not reported.  
Cough, cough, cough 
(Midland Cancer 
Network) 
http://tinyurl.com/8d
pupu2 
 
NZ, 2010  Awareness raising campaign aimed at improving the 
early detection of lung cancer in Rotorua, NZ.  This 
was based on a push-pull model.  In the push 
element, the aim was to encourage individuals 
(especially smokers) with a persistent cough to see 
their doctor.  In the pull element, health care 
workers were encouraged to promote the early 
detection of lung cancer and seek help earlier.   
1. Behaviour Change Goal: increase visits to GP and health professionals 
2. Formative Research: not reported 
3. Target Groups: Smokers 
4. Theory: not reported 
5. Communication Strategy: There is only very limited information regarding the 
specific communication strategy adopted in this campaign.  However, it 
appears that the campaign was based on posters and brochure material 
promoting the importance of seeking help from a health professional in 
response to a persistent cough. 
Not reported. 
The sooner the better 
(Northern Cancer 
Network) 
http://tinyurl.com/9n
k2qd8 
NZ, 2010  Campaign aimed at increasing awareness of lung 
cancer symptoms in Maori and Pacific populations.  
The campaign involved outlining the main symptoms 
of lung cancer (e.g. persistent cough, chest pain, 
persistent chest infection, coughing up blood).  
Individuals with these symptoms were encouraged 
to contact their nurse, doctor, local health worker, or 
the Healthline phone number.  GPs and other health 
care workers were advised of the program.   
1. Behaviour Change Goal: increase visits to nurse, doctor, local health worker, or 
Healthline phone number 
2. Formative Research: focus groups with target audience, and consultations with 
clinicians and researchers 
3. Target Groups: Adults aged 45–64 years with Maori and Pacific backgrounds. 
4. Theory: not reported 
5. Communication Strategy: this campaign included a combination of radio 
advertisements and newspaper articles disseminated across specific areas of 
Northern New Zealand. 
Not reported. 
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Lung cancer interventions with a ‘signs and symptoms’ component 
Campaign 
Country and 
year 
Description of Campaign Campaign Characteristics Results 
The Australian Lung 
Foundation (various 
campaigns) 
http://www.lungfoun
dation.com.au/shinea
lightonlungcancer 
http://www.lungfoun
dation.com.au/showu
syourlungs 
Australia, 2011 The Australian Lung Foundation ran a variety of 
campaigns to raise awareness of lung cancer in 2011; 
these coincided with Lung Health Awareness month 
in 2011 and World COPD day.  These campaigns 
included ‘Lung Cancer Doesn’t Discriminate’, ‘Shine a 
Light On Lung Cancer’, and ‘Show us your lungs’.   
1. Behaviour Change Goal: increase lung cancer screening (i.e., increase GP visits) 
2. Formative Research: Not reported 
3. Target Groups: No clear target groups, but appeared to be focused on smokers 
and individuals exposed to asbestos 
4. Theory: not reported 
5.  Communication Strategy: This varied depending on the campaign.  These 
included face-to-face events, posters, and online information (through the 
Australian Lung Foundation website). 
Not reported. 
Find Cancer Early 
Cancer Council WA 
http://tinyurl.com/9w
669ep 
Australia, year 
not reported  
Two-year campaign aimed at increasing awareness 
of the signs and symptoms of bowel, lung, prostate, 
and breast cancer in adults aged 40 years and over in 
regional WA.  The campaign aimed to increase 
awareness of the main symptoms, and encourage 
people to visit their doctor. The lung cancer 
component focused on the following symptoms: a 
persistent cough, coughing up blood, breathlessness, 
repeated chest infections.    
1. Behaviour Change Goal: increase visits to GP 
2. Formative Research: not reported 
3. Target Groups: Adults aged 40 years and over, residing in regional WA 
4. Theory: not reported 
5. Communication Strategy: The communication strategy was primarily based on 
DVD, posters and brochures which were distributed to members of the 
community in the target group. 
Not reported. 
Detect Cancer Early 
(NHS) 
Scottish Government 
2011. 
Scotland, lung 
cancer 
component 
planned for 
2013  
A social marketing campaign aimed at overcoming 
the fear associated with cancer and improving 
awareness levels of cancer signs and symptoms.  The 
campaign is targeted at breast, lung, and bowel 
cancer. 
1. Behaviour Change Goal: increase visits to GP 
2. Formative Research: not reported 
3. Target Groups: not reported 
4. Theory: not reported 
5. Communication Strategy: Detect Cancer Early is a large social marketing 
campaign that includes a lung cancer component which will begin in 2013.  
Specific details of the lung cancer component are not yet available. 
Not reported. 
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Appendix C. Breast, colorectal and prostate cancer interventions with a signs 
and symptoms component 
Campaign 
Setting and 
year Description of Campaign Campaign Characteristics Results 
Breast Cancer 
Catalano et al. 2003. USA, data 
collected from 
Atlanta, Detroit 
and San 
Francisco 
metropolitan 
areas from 
1985–2002 
Evaluation of the impact of the Breast Cancer 
Awareness Month programme on awareness 
of breast cancer symptoms, and screening and 
detection of breast cancer. Breast Cancer 
Awareness Month is a national mass media 
campaign focusing on breast cancer awareness 
and screening, targeting large populations. The 
campaign has national and local components, 
and involves a number of partner stakeholders.  
1. Behaviour Change Goal: No reported outcomes measures for 
awareness of signs and symptoms of breast cancer – only reports 
rates of detection of breast tumours 
2. Formative Research: Not reported 
3. Target Groups: not reported – targeted at large populations of 
females 
4. Theory:  not reported    
5. Communication Strategy: National and local media campaign 
involving PR/media relations, print advertising and TV advertising. 
No data reported in relation to signs and 
symptoms of breast cancer. 
Evaluation reported that during Breast 
Cancer Awareness month quarters of the 
year from 1985–2002 approximately 790 
more tumours than expected were 
detected. 
Quality of evidence: High.  
Gabram et al. 2008. USA , Atlanta 
Georgia 2001–
2004 
A community outreach and internal navigation 
programme to improve outcomes in relation to 
breast cancer among African America women. 
125 trained community health advocates 
(CHAs) provided educational programmes to 
the community to encourage screening, 
diagnostic procedures (including recognising 
signs and symptoms) and treatment.  
1. Behaviour Change Goal: No reported outcome measures for 
awareness of signs and symptoms of breast cancer – only reports 
rates of detection of breast cancer 
2. Formative Research: Not reported 
3. Target Groups: African America females in Georgia, Atlanta 
4. Theory:  not reported  
5. Communication Strategy: CHAs provided educational sessions in the 
community encouraging screening, increase breast cancer 
awareness, teach the importance of self examination and 
encourage participants to see a trained healthcare provider if any 
symptoms were found. 
No data reported in relation to signs and 
symptoms of breast cancer. 
487 patients were diagnosed and treated 
for breast cancer 2001–2004. Since 2001, 
there were 1148 community 
interventions by CHAs reaching, >10,000 
participants. From 2001–2004 the 
proportion of stage 0 breast cancers 
increased from 12.4% to 25.8% and there 
was a decline in stage IV breast cancers 
from 16.8% to 9.4%. 
Quality of evidence: Low.  
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Breast, colorectal and prostate cancer interventions with a ‘signs and symptoms’ component 
Campaign 
Setting and 
Year Description of Campaign Campaign Characteristics Results 
Breast Cancer 
Promoting Early 
Presentation (breast 
cancer) 
Linsell et al. 2009. 
Forbes et al. 2011. 
UK, 2007–2008 This was a RCT conducted to compare the 
efficacy of two versions of an intervention to 
promote early diagnosis of breast cancer.  The 
intervention was targeted towards older 
females who had received free breast cancer 
screening as part of the NHS Breast Screening 
Programme.  The intervention was delivered 
during each patient’s final mammogram as part 
of the programme and aimed to increase 
awareness of breast cancer signs and 
symptoms, and encourage females to continue 
screening.  Participants were randomised to 
one of three conditions: (1) usual care (i.e. 
recommendation from screening unit 
receptionist to have regular mammograms); (2) 
the booklet (information on breast cancer signs 
and symptoms, and importance of regular 
screening); (3) booklet plus interaction with 
radiographer—this reinforced messages in the 
booklet, with instructions on how to check for 
signs and symptoms of breast cancer.  
1. Behaviour Change Goal: Breast cancer awareness – measured using 
a validated questionnaire asking about knowledge of breast cancer 
symptoms, knowledge of risk of breast cancer, and breast checking 
behaviour 
2. Formative Research: the intervention was developed on the basis of 
a pilot trial over a 6 month period  
3. Target Groups: females aged 67–70 years, receiving their final 
mammogram as part of the NHS Breast Screening Programme 
4. Theory:  the intervention was based on a theoretical model 
developed by Bish et al. (2005) which proposed factors influencing 
help seeking behaviour for breast cancer.  This includes factors such 
as attitudes, intentions, and knowledge of symptoms 
5. Communication Strategy: depending on the condition; the most 
extensive communication included a face-to-face component with a 
radiographer and a booklet provided to each participant, which 
included information of breast cancer signs and symptoms, and 
recommendations for future breast cancer screening. 
At one and 12 month follow up, patients 
in the interaction plus booklet condition 
and booklet alone condition were more 
breast cancer aware.  For example, 33% 
and 13% of patients in the interaction 
plus booklet and booklet only conditions 
were breast cancer aware compared to 
4% in the control group.   
These effects were sustained at 12 
months and 24 months.  At 2 years the 
PEP intervention increased the 
proportion who were breast cancer 
aware compared with usual care (21% vs 
6% odds ratio 8.1, 95% CI: 2.7–25.0). 
Quality of Evidence Rating: High. 
Rimer et al. 2002. USA, North 
Carolina, 1997–
2000 
RCT to assess the effects of a mammography 
decision making intervention to increase 
knowledge about breast cancer and 
mammography, accuracy of breast cancer risk 
perceptions, and use of mammography, in 
which women aged 40–44 years and 50–54 
years enrolled in Blue Cross Shield health 
insurance were randomly assigned to one of 
three groups: usual care (UC) n=378, tailored 
print (TP) materials n=374), or tailored print 
materials plus tailored telephone counselling 
(TC) n=339. 
1. Behaviour Change Goal: Knowledge about breast cancer and 
mammography, accuracy of breast cancer risk perceptions, use of 
mammography 
2. Formative Research: Baseline telephone interviews were conducted 
to inform the tailoring of intervention materials: printed materials 
and telephone counselling 
3. Target Groups: 1091 women aged 40–44 years and 50–54 years in 
North Carolina 
4. Theory:  Messages and materials were tailored on variables from 
the Transtheoretical model (TTM) 
5. Communication Strategy: Tailored booklets mailed to participants in 
year one containing different messages according to responses 
given in baseline survey interview and according to TTM. Second 
tailored print intervention mailed following 12 month follow up 
At 12 and 24 months, women who 
received telephone TP & TC had 
significantly greater knowledge and more 
accurate breast cancer risk perceptions - 
2.3 times more likely to answer correctly 
than those in UC, and were 40% more 
likely to have had mammograms. 
Women in TP group had significant 
effects for knowledge and accuracy but 
were less likely to have had a 
mammogram. 
Quality of Evidence Rating: High. 
Breast, colorectal and prostate cancer interventions with a ‘signs and symptoms’ component 
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Campaign 
Setting and 
Year Description of Campaign Campaign Characteristics Results 
Breast Cancer 
interview was a newsletter designed to reinforce and update the 
booklet. Following both waves of print interventions, trained 
counsellors called women in the assigned group to discuss 
questions and concerns regarding breast cancer and 
mammography.  
Learn, Share and 
Live 
Skinner et al. 2000. 
Skinner et al. 1998. 
USA, St Louis, 
Missouri, 1995–
1996. 
A community based breast cancer education 
programme entitled Learn, Share & Live, 
targeted at older urban African American 
women implemented through an urban social 
service organisation – System to Assure Elderly 
Services (STAES). 
1. Behaviour Change Goal: Knowledge of breast cancer and 
mammography, level of mammography screening 
2. Formative Research: Baseline survey conducted with target 
population and STAES workers to inform intervention protocol.  
3. Target Groups: 323 Older urban African American women, mean 
age 73.6 years 
4. Theory: Intervention messages were based on the Health Belief 
Model and Social Cognitive Theory 
5. Communication Strategy: Steering committee of healthcare & 
community experts informed intervention design. Trained STAES 
workers delivered educational training in community. Use of peer to 
peer networking. Programme brochures and posters. 
From baseline to year 2 mean knowledge 
score of breast cancer among 
participants increased from 3.4 to 4.1. 
The percentage of women adherent to 
screening increased from 40% to 68%.  
Quality of Evidence Rating: High (quasi-
experimental, group randomised 
crossover design). 
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Breast, colorectal and prostate cancer interventions with a ‘signs and symptoms’ component 
Campaign 
Setting 
and 
Year 
Description of Campaign Campaign Characteristics Results 
Colorectal Cancer 
Be Clear on 
Cancer (bowel 
cancer 
component) 
 
Mayden 
Research 
2011. 
UK, 2011 Seven week campaign that aimed to increase 
the awareness of signs and symptoms of bowel 
cancer and encourage people to seek help from 
their GP if they have had symptoms for ≥ 3 
weeks. 
1. Behaviour Change Goal: increased GP visits for signs and symptoms of bowel 
cancer 
2. Formative Research: The intervention was based on a pilot conducted in one 
cancer network in 2010 
3. Target Groups: Adults aged over 55 years in lower socio-economic groups and key 
influencers such as family and friends 
4. Theory: not reported 
5. Communication Strategy: the campaign messages, highlighting the symptoms of 
blood in stool or looser stool for 3 weeks or more, were disseminated through 
posters and TV, radio, and newspaper coverage, as well as live events. Materials 
address barriers to presentation such as belief that they might be wasting time or 
putting a strain on the health system. Screening kits sent out to people aged 60–69 
every two years. Messaging also offered advice on lifestyle behaviour to reduce 
cancer risk. Information sessions and training conducted with GPs and pharmacies. 
Evaluation data were available for 
74 practices across three cancer 
networks in the UK: Mount Vernon, 
Anglia and Avon, Somerset and 
Wiltshire.   
 
Statistically significant increases in 
the public’s unprompted awareness 
of blood in poo (27% to 42%) and 
looser poo (10% to 23%). 
 
There were significant increases 
(48%) in GP attendances for the 
three symptoms mentioned in the 
campaign. 
 
Quality of Evidence Rating: Low. 
Broadwater 
et al. 2004. 
US, Utah, 
2003 
A colon cancer awareness media campaign to 
increase public awareness about the importance 
of early detection and prevention of colon 
cancer aimed at those over 50 years of age.  
 
The campaign message was that there are no 
early warning signs of colon cancer, so adults 
aged 50 or older are encouraged to contact their 
doctor to find the appropriate colon cancer 
screening option. 
 
1. Behaviour Change Goal: Campaign awareness and recall of messages 
2. Formative Research: Market research through telephone interviews to assess 
public knowledge, attitudes and behaviour regarding colon cancer. Survey was 
informed by pilot testing in 23 randomly selected Utah residents. Focus group 
testing of campaign messages was also conducted 
3. Target Groups: Adults aged 50 years or over in Utah 
4. Theory: Not reported 
5. Communication Strategy: TV, radio & print advertising, public relations, celebrity 
spokespersons, GP public appearances at road show events, TV broadcasting of a 
colonoscopy, grassroots efforts through stakeholders: parent-teacher associations, 
business, physicians, health departments. 
409 respondents completed the 
colon cancer survey.  At baseline 
only 36% of survey respondents had 
seen or heard advertising about 
colon cancer. This increased to 79% 
after the campaign. Of the 79% that 
had seen or heard an advert, 85% 
could recall one of the main 
campaign messages.  
 
Quality of Evidence Rating: Low. 
Screen for Life 
Jorgenesen et 
al. 2001. 
US, 
National 
Campaign, 
1999–
Screen for Life is a national multimedia 
campaign conducted by the Center for Disease 
Control and Prevention, to raise awareness 
about colorectal cancer, and encourage men and 
1. Behaviour Change Goal: Raising awareness of the seriousness of colorectal cancer 
and encouraging people to speak to a physician about getting screened for 
colorectal cancer 
No data on knowledge or attitudes.  
Process evaluation shows that 
Screen for Life PSAs have generated 
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Campaign 
Setting 
and 
Year 
Description of Campaign Campaign Characteristics Results 
Colorectal Cancer 
CDC, 2012. ongoing women aged 50 or older to speak to their GP 
about being screened.  
2. Formative Research: Extensive review of communication & behavioural science 
literature. Key informant interviews, and focus groups with target audiences (74 
groups in 30 cities) to explore attitudes and behaviours and test message concepts 
and materials 
3. Target Groups: Men and women aged 50 years or older, with targeted components 
aimed at African Americans, Hispanics, Alaska Natives and Medicare beneficiaries 
4. Theory: Formative research process, and campaign messages and materials were 
based on Social Cognitive Theory, and the Theory of Planned Behaviour 
5. Communication Strategy: TV public service announcements (PSAs), posters, 
brochures, factsheets, radio PSAs, including materials targeted at specific sub 
populations (e.g. Hispanics – Spanish language materials). Materials include 
information on signs & symptoms: blood in or on your stool, pain aches or cramps 
in your stomach that don’t go away, losing weight and you don’t know why.  
more than 10 billion audience 
impressions (number of times seen 
or heard by audience members).  
A National Health Survey indicated 
overall rates of screening for 
colorectal cancer among 
respondents aged 50 or over 
increased from 53.8% to 64.2% 
between 2002 and 2008. 
Quality of Evidence: Low. 
West of 
Scotland 
Cancer 
Awareness 
Project 
(WoSCAP) 
Eadie and 
MacAskill 
2002. 
Eadie and 
MacAskill 
2008. 
Cancer 
Research UK 
2007. 
 
UK, West 
of 
Scotland, 
2004–
2005 
This was a social marketing campaign aimed to 
increase awareness of the signs and symptoms 
of bowel cancer and encourage those with 
symptoms to present to a GP. 
1.  Behaviour Change Goal: To increase awareness of signs and symptoms of bowel 
cancer, and to increase rates of presentation to a GP 
2. Formative Research: Extensive formative research with the target audience 
including focus groups and interviews to identify knowledge, attitudes, behaviours 
and barriers. Extensive consultations with professional stakeholders was also 
undertaken to identify issues within the healthcare system 
3. Target Groups: Males and females aged 40–70 in lower socio-economic groups 
4. Theory: the campaign was informed by Social Cognitive Theory, which 
conceptualises human behaviour as being the result on individual factors (e.g. 
knowledge) and the environment (e.g. social norms, the physical environment) 
5. Communication Strategy: TV and radio advertising, posters and literature 
(booklets, leaflets), consultation and support of clinicians and nurse specialists, 
local implementation teams to facilitate smooth running of the intervention.  
Prompted awareness of the 
campaign reached 71%, awareness 
of coverage of bowel cancer in the 
media increased from 39% at 
baseline to 68% at follow up. 
Awareness of bleeding as a 
symptom increased from 62% to 
71% and awareness of blood in 
motions almost doubled from 15% 
to 29%. An approximate 10% 
increase in referrals from GPs 
occurred due to the campaign.  
In one participating hospital – 
Hairmyres – six tumours and 18 
polyps were detected and treated 
through patients presenting directly 
as a result of the campaign.  
Quality of Evidence Rating: Low. 
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Campaign 
Setting 
and 
Year 
Description of Campaign Campaign Characteristics Results 
Prostate Cancer 
Ilic et al. 2007. Australia, 
not 
specified 
This intervention involved providing educational 
materials via video, internet, and pamphlet 
about cancer screening (including knowledge of 
prostate cancer).  The aim was to compare the 
three methods of delivery on knowledge, 
attitudes, and decision making/screening 
intentions for prostate cancer.  
1. Behaviour Change Goal: no specific behaviour change goal; the intervention was 
targeted towards knowledge and awareness 
2. Formative Research: there was no clear evidence for formative research.  However, 
there was some suggestion that the authors did conduct a literature review to 
develop the three methods of delivery 
3. Target Groups: males aged 45 years and over who had not been tested for prostate 
cancer 
4. Theory: not reported 
5. Communication Strategy: The educational material was delivered via pamphlet, 
video, or internet. 
The educational materials led to a 
27% increase in knowledge about 
prostate cancer (pre and post 
comparison). 
The magnitude of this increase was 
similar between the three methods of 
delivery.   
Quality of Evidence Rating: Low. 
 
Prostate Man 
Lyzun et al. 
2008. 
Canada, 
2007 
This is a social marketing campaign aimed at 
improving awareness of prostate cancer among 
males in North-western Ontario.  This campaign 
was centred on a fictional comic book character 
(‘Prostate Man’), and was intended to use 
elements of humour to engage with the target 
audience and communicate the campaign 
messages.  The campaign evolved over a period 
of time (2002–2007) and consisted of posters, 
cartoons, radio and television advertisements to 
raise awareness of prostate cancer signs and 
symptoms, as well as the importance of health 
behaviours such as visiting a health care 
professional, eating healthily, and engaging in 
physical activity. 
1. Behaviour Change Goal: this campaign has several behaviour change goals.  For 
example, it aimed to encourage males to visit their healthcare provider regarding 
prostate health (including cancer).  In addition, the campaign promoted other 
health behaviours associated with diet and physical activity   
2. Formative Research: the campaign was informed by research indicating the 
importance of role models in relation to health seeking behaviours.  The campaign 
appeared to have been informed by relevant behaviour change principles 
(although no specific behaviour change model is referred to)  
3. Target Groups: males aged 50 years and over 
4. Theory: although some components of behaviour change models were noted, the 
campaign did not appear to have been informed by a relevant theory 
5. Communication Strategy: The campaign used a variety of communication channels 
including posters, cartoons, and advertisements placed on television and radio. 
Data have been reported on the 
number of people who visited the 
Prostate Man website in 2007; this 
included the average amount of time 
that people spend on the website.   
However, there are no formal 
evaluation data examining the effects 
of this campaign on awareness of 
prostate cancer signs and symptoms, 
or on the behaviour change goals. 
Quality of Evidence: Very low. 
 
